|反式-3,4-双(3-羟基苄基)二氢呋喃-2(3H)-酮|CsnPharm

CAS No.: 78473-71-9

Enterolactone Catalog No. CSN20489

Synonyms: (±)-Enterolactone;HPMF

Enterolactone is a mammalian lignan formed by the action of intestinal bacteria from plant lignan precursors present in the diet and is potential anti-cancer effect.

规格	价格	促销价格	库存	数量

400-920-2911

sales@csnpharm.cn

tech@csnpharm.cn

加入购物车大规格询价

加入收藏

产品咨询

400-920-2911

sales@csnpharm.cn

tech@csnpharm.cn

纯度 & 质量文件批次:

靶点选择性

生物活性

实验方案

技术信息

生物活性

描述Enterolactone is a mammalian lignan formed by the action of intestinal bacteria from plant lignan precursors present in the diet and is potential anti-cancer effect.
临床研究

NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点
NCT02014181	Cystic Fibrosis ... more >> Oxidative Stress Inflammation Collapse <<	Phase 1	Completed	-	United States, Pennsylvania ... more >> University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Collapse <<
NCT01314586	Hypercholesterolemia	Not Applicable	Completed	-	United States, Iowa ... more >> Nutrition & Wellness Research Center Ames, Iowa, United States, 50011 Collapse <<
NCT02132728	Metabolic Syndrome	Not Applicable	Completed	-	Brazil ... more >> Clinical Hospital of Ribeirao Preto Ribeirão Preto, São Paulo, Brazil, 14049-900 Collapse <<

更多
参考文献

[1] Xiong XY, Hu XJ, et al. Inhibitory Effects of Enterolactone on Growth and Metastasis in Human Breast Cancer. Nutr Cancer. 2015;67(8):1324-32.
[2] Buck K, Vrieling A, et al. Serum enterolactone and prognosis of postmenopausal breast cancer. J Clin Oncol. 2011 Oct 1;29(28):3730-8.

实验方案

计算器摩尔计算器总药量计算器工作液计算器
储存液制备
- 1 mg
- 5 mg
- 10 mg
- 1 mM
- 3.3520 mL
- 16.7598 mL
- 33.5196 mL
- 5 mM
- 0.6704 mL
- 3.3520 mL
- 6.7039 mL
- 10 mM
- 0.3352 mL
- 1.6760 mL
- 3.3520 mL

技术信息

CAS号	78473-71-9	储存条件	粉末液体 -20°C:3-6 月 -80°C:12月
分子式	C18H18O4	运输	蓝冰
分子量	298.33	别名	(±)-Enterolactone;HPMF

大规格询价

号为必填项

姓名: 邮箱: 手机号:

留言:

提交

NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点

NCT02014181	Cystic Fibrosis ... more >> Oxidative Stress Inflammation Collapse <<	Phase 1	Completed	-	United States, Pennsylvania ... more >> University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Collapse <<
NCT01314586	Hypercholesterolemia	Not Applicable	Completed	-	United States, Iowa ... more >> Nutrition & Wellness Research Center Ames, Iowa, United States, 50011 Collapse <<
NCT02132728	Metabolic Syndrome	Not Applicable	Completed	-	Brazil ... more >> Clinical Hospital of Ribeirao Preto Ribeirão Preto, São Paulo, Brazil, 14049-900 Collapse <<
NCT01531569	Diabetes Mellitus, Type 2 ... more >> Hypercholesterolemia Collapse <<	Phase 2	Completed	-	Canada, Saskatchewan ... more >> Saskatoon Centre for Patient Oriented Research - Saskatoon City Hospital Saskatoon, Saskatchewan, Canada, S7K 0M7 Collapse <<
NCT01234506	Oxidative Stress ... more >> Inflammation Aging Dementia Pain Collapse <<	Phase 2	Completed	-	Canada, Saskatchewan ... more >> Saskatoon Health Region Saskatoon, Saskatchewan, Canada, S7K 5T6 Collapse <<
NCT03421184	Lupus Erythematosus ... more >> Rheumatoid Arthritis Autoimmune Thrombocytopenia Collapse <<	Not Applicable	Recruiting	November 2020	France ... more >> CHU de Bordeaux - service de médecine interne Recruiting Pessac, France Contact: Jean-François VIALLARD, Prof 05.57.65.64.83 ext +33 jean-françois.viallard@chu-bordeaux.fr Contact: Isabelle RAYMOND, Pharm Principal Investigator: Jean-François VIALLARD, Prof Sub-Investigator: Estibaliz LAZARO, Prof Sub-Investigator: Jean-Luc PELLEGRIN, Prof Sub-Investigator: Carine GREIB, MD Sub-Investigator: Irene MACHELARD, MD Sub-Investigator: Marion MIRABEL, MD Sub-Investigator: Etienne RIVIERE, MD Sub-Investigator: Thierry SCHAEVERBEKE, Prof Sub-Investigator: Christophe RICHEZ, Prof Sub-Investigator: Marie-Elise TRUCHETET, MD Sub-Investigator: Nicolas POURSAC, MD Sub-Investigator: Nadia MEHSEN, MD Collapse <<
NCT02353234	Dietary Modification	Not Applicable	Completed	-	Italy ... more >> University of Parma - Department of Food Science Parma, Italy, 43125 Collapse <<
NCT01089049	Breast Cancer	Phase 1 Phase 2	Completed	-	Canada, Ontario ... more >> Nutrasource Diagnostics Inc Guelph, Ontario, Canada, N1G0B4 Collapse <<

Enterolactone Catalog No. CSN20489

靶点选择性

请登录您的专属账户

确认信息